SEC Form 4 · accession 0001179110-16-027511
Esperion Therapeutics, Inc. · ESPR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark E McGovern
Director
Period of report
Jul 5, 2016
Accepted (ET)
Jul 7, 2016 · 7:17 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001434868
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 5, 2016 | P | 600 | $10.00 | A | 600 | D | |
| Common Stock | Jul 6, 2016 | P | 4,400 | $10.00 | A | 5,000 | D |
Table II — derivative securities
No Table II lines on this filing.